title: Idiopathic hypoalbuminemia explained by reduced synthesis rate and an increased catabolic rate.
abstract: OBJECTIVE
  To determine the contribution of albumin synthetic and catabolic rates to steady state levels in a patient with idiopathic hypoalbuminemia.
  
  
  METHODS
  Using L-[1-(13)C] valine, both FSR (fractional synthesis rate) as well as FCR (fractional catabolic rate) were studied. Human albumin cDNA analysis and determination of the exact albumin mass by electrospray mass spectrometry were performed.
  
  
  RESULTS
  Compared with controls, plasma albumin concentration in the patient was reduced (6.7 vs. 37.0 +/- 2.6 g/L). Albumin FSR (= FCR in steady state) was increased compared to controls. The ASR (absolute synthesis rate) of albumin was decreased based on the enrichment in plasma valine and KIV, but estimated to be normal based on VLDL apoB100 at plateau compared to controls. Direct estimation of albumin FCR rejected the latter. No mutation was found in the transcribed region of albumin gene. The exact mass of albumin (66.493 Da) was not different from controls.
  
  
  CONCLUSIONS
  The hypoalbuminemia was a result of accelerated clearance of albumin from plasma in addition to defective albumin synthesis. This study also shows that the chosen method of the precursor pool could lead to misinterpretation of data in hepatic protein synthesis.
authors.affiliation: Department of Vascular Medicine and Metabolism, University Medical Center, Utrecht, The Netherlands. B.Prinsen@azu.nl
authors.forename: Berthil H C M T
authors.initials: BH
authors.lastname: Prinsen
authors.forename: George A
authors.initials: GA
authors.lastname: Kaysen
authors.forename: Leo W J
authors.initials: LW
authors.lastname: Klomp
authors.forename: Jose
authors.initials: J
authors.lastname: de Boer
authors.forename: P Hugh R
authors.initials: PH
authors.lastname: Barrett
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Thornalley
authors.forename: Sinan
authors.initials: S
authors.lastname: Battah
authors.forename: Ruud
authors.initials: R
authors.lastname: Berger
authors.forename: Ton J
authors.initials: TJ
authors.lastname: Rabelink
authors.forename: Monique G M
authors.initials: MG
authors.lastname: de Sain-van der Velden
mesh_terms: D000328:Adult; D000596:Amino Acids / Q000302:isolation & purification / Q000378:metabolism; D001055:Apolipoproteins B / Q000145:classification / Q000302:isolation & purification / Q000378:metabolism; D001797:Blood Protein Electrophoresis; D002247:Carbon Isotopes; D035061:Control Groups; D004247:DNA / Q000032:analysis / Q000235:genetics / Q000378:metabolism; D006801:Humans; D034141:Hypoalbuminemia / Q000378:metabolism*; D007700:Kinetics; D008297:Male; D008954:Models, Biological; D010421:Pentanoic Acids / Q000302:isolation & purification / Q000378:metabolism; D012709:Serum Albumin / Q000235:genetics / Q000378:metabolism*; D021241:Spectrometry, Mass, Electrospray Ionization; D014633:Valine / Q000378:metabolism / Q000493:pharmacokinetics
chemical_list: D000596:Amino Acids; D001055:Apolipoproteins B; D002247:Carbon Isotopes; D010421:Pentanoic Acids; D012709:Serum Albumin; D004247:DNA; D014633:Valine